Resona Asset Management Co. Ltd. Cuts Holdings in American Healthcare REIT, Inc. $AHR

Resona Asset Management Co. Ltd. reduced its holdings in American Healthcare REIT, Inc. (NYSE:AHR) by 3.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 63,985 shares of the company’s stock after selling 2,525 shares during the quarter. Resona Asset Management Co. Ltd.’s holdings in American Healthcare REIT were worth $2,312,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. GAMMA Investing LLC raised its position in American Healthcare REIT by 22.1% in the second quarter. GAMMA Investing LLC now owns 1,716 shares of the company’s stock worth $63,000 after acquiring an additional 311 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of American Healthcare REIT by 1.4% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 29,300 shares of the company’s stock valued at $1,086,000 after purchasing an additional 393 shares in the last quarter. Lion Street Advisors LLC increased its holdings in shares of American Healthcare REIT by 6.2% in the 2nd quarter. Lion Street Advisors LLC now owns 7,373 shares of the company’s stock valued at $271,000 after purchasing an additional 430 shares in the last quarter. Benjamin Edwards Inc. lifted its stake in shares of American Healthcare REIT by 3.2% in the first quarter. Benjamin Edwards Inc. now owns 14,368 shares of the company’s stock valued at $435,000 after purchasing an additional 444 shares during the period. Finally, Xponance Inc. boosted its holdings in American Healthcare REIT by 4.3% during the first quarter. Xponance Inc. now owns 11,489 shares of the company’s stock worth $348,000 after buying an additional 470 shares in the last quarter. Institutional investors and hedge funds own 16.68% of the company’s stock.

Insider Activity

In other American Healthcare REIT news, Director Jeffrey T. Hanson sold 20,010 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $49.68, for a total value of $994,096.80. Following the transaction, the director directly owned 21,798 shares in the company, valued at approximately $1,082,924.64. This represents a 47.86% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Mark E. Foster sold 3,850 shares of American Healthcare REIT stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total transaction of $161,276.50. Following the sale, the executive vice president owned 59,100 shares of the company’s stock, valued at approximately $2,475,699. This trade represents a 6.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Truist Financial lifted their price target on shares of American Healthcare REIT from $44.00 to $46.00 and gave the company a “buy” rating in a research report on Tuesday, August 26th. Morgan Stanley reaffirmed an “overweight” rating on shares of American Healthcare REIT in a research note on Wednesday, September 3rd. Weiss Ratings reiterated a “hold (c)” rating on shares of American Healthcare REIT in a research report on Wednesday, October 8th. Royal Bank Of Canada upped their target price on American Healthcare REIT from $39.00 to $45.00 and gave the company an “outperform” rating in a report on Wednesday, August 13th. Finally, UBS Group began coverage on American Healthcare REIT in a research note on Friday, September 19th. They set a “buy” rating and a $51.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $46.50.

American Healthcare REIT Stock Performance

American Healthcare REIT stock opened at $49.35 on Tuesday. American Healthcare REIT, Inc. has a fifty-two week low of $25.87 and a fifty-two week high of $50.51. The company has a market capitalization of $8.32 billion, a price-to-earnings ratio of 352.50, a PEG ratio of 2.44 and a beta of 0.98. The stock has a fifty day moving average of $43.09 and a two-hundred day moving average of $39.03. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.48 and a current ratio of 0.48.

American Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, October 17th. Investors of record on Tuesday, September 30th were paid a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $1.00 annualized dividend and a yield of 2.0%. American Healthcare REIT’s payout ratio is presently 714.29%.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.